Activity of Steroid 4 and Derivatives 4a–4f as Inhibitors of the Enzyme 5α-Reductase Type 1
June 2018
in “
Bioorganic & medicinal chemistry
”
steroid derivatives 5α-reductase type 1 5α-R1 inhibitors metastatic prostate bone tumors in vitro assays in vivo experiments gonadectomized hamsters flank glands prostate seminal vesicles plasma half-life hydrolysis prodrugs metastatic prostate cancer 5-alpha-reductase type 1 5-alpha-R1 prostate cancer
Studysummary This study identified that derivatives 4, 4b, and 4c strongly inhibited the enzyme type 1 5α-reductase and decreased reproductive organ weights in hamsters, suggesting potential as prodrugs for prostate tumor growth inhibition.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study synthesized and tested seven steroid derivatives (4, 4a–4f) as inhibitors of the enzyme 5α-reductase type 1 (5α-R1), which is predominant in metastatic prostate bone tumors. In vitro assays showed that compounds 4, 4b, and 4c effectively inhibited 5α-R1 activity. In vivo experiments on gonadectomized hamsters demonstrated that these derivatives reduced the diameter of flank glands and the weight of prostate and seminal vesicles without significant toxicity. The derivatives exhibited improved plasma half-life due to their stability against hydrolysis, with compound 4e showing the greatest pharmacological effect. The study concluded that these derivatives could serve as potential prodrugs for treating metastatic prostate cancer.
